Praxis Precision Medicines announces Nasdaq Rule 5635(c)(4) inducement grants
Praxis Precision Medicines said its Board Compensation Committee approved inducement grants under Nasdaq Listing Rule 5635(c)(4) on September 1, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.